Bayesian Capital Management, LP Medifast Inc Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$192.64 - $288.27 $137,544 - $205,824	-714 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$217.95 - $332.25 $155,616 - $237,226	714 New	714 $202,000
Q4 2018 Feb 13, 2019	SELL	$114.93 - $220.1 $1.23 Million - $2.35 Million	-10,692 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$158.99 - $255.94 $429,273 - $691,038	2,700 Added 33.78%	10,692 $2.37 Million
Q2 2018 Aug 14, 2018	BUY	$91.9 - $176.53 $494,605 - $950,084	5,382 Added 206.21%	7,992 $1.28 Million
Q1 2018 May 15, 2018	SELL	$63.32 - $93.45 $71,868 - $106,065	-1,135 Reduced 30.31%	2,610 $244,000
Q4 2017 Feb 12, 2018	BUY	$59.51 - $73.52 $222,864 - $275,332	3,745	3,745 $261,000

164

9.07M

520K

301K

Ticker MED
Exchange NYSE
Sector Consumer Cyclical
Industry Personal Services
Shares Outstandng 11,017,900
Market Cap $203M
Description
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.